Millions of Americans who buy health coverage through the Affordable Care Act marketplaces are now paying roughly twice what they paid a year ago. Average annual premium payments for subsidized buyers hit $1,904 after enhanced premium tax credits expired, up from $888 when those temporary boosts were still in place. The jump traces directly to the sunset of enhanced subsidies first created under the American Rescue Plan Act, and it arrives just as federal projections warn that 2.2 million people could lose coverage in 2026.
Why the premium jump from $888 to $1,904 hits hardest in 2026
The gap between $888 and $1,904 is not an abstract modeling exercise. It reflects the mechanical result of reverting to original ACA contribution percentages after years of temporarily lower caps. The IRS contribution schedule for the 2026 coverage year restores the pre-ARPA formula, which asks households to cover a larger share of their benchmark premium. For a family earning just above 400 percent of the federal poverty level, the change can mean going from a near-zero net premium to hundreds of dollars a month overnight.
That price shock creates a specific enrollment risk. States where benchmark premiums already run above the national average, and where a larger share of enrollees cluster near the old 400 percent FPL eligibility cliff, face steeper drop-off pressure. The Congressional Budget Office projects that 2.2 million additional people will be uninsured in 2026 if the enhanced credits are not restored, according to a Congressional Research Service review. But that figure is a national average. In high-cost states with thinner insurer competition, the erosion could outpace the CBO baseline once actual 2026 open enrollment numbers arrive.
CBO and CRS projections behind the $1,904 average
The $1,904 versus $888 comparison comes from modeling that isolates the subsidy rollback as the dominant cost driver. CBO projects gross benchmark premiums will increase 4.3 percent in 2026 without the enhanced credits, a figure cited in the same CRS report. That premium inflation compounds the contribution-percentage reversion: enrollees face both higher sticker prices and a larger required share of those prices.
Cynthia Cox of KFF, a nonpartisan health policy research organization, has commented publicly on the effects of the subsidy expiration. Her analysis aligns with the CBO and CRS findings, pointing to middle-income enrollees as the group absorbing the sharpest cost increase. Households that previously paid little or nothing for a silver-tier benchmark plan now confront monthly bills that could push them toward skimpier coverage or out of the marketplace entirely.
On the supply side, federal data show that insurer participation remains broad. The Centers for Medicare & Medicaid Services reports in its 2026 marketplace fact sheet that most counties continue to offer multiple issuers and plan options. Insurer exits or plan withdrawals are not driving the affordability problem. The subsidy rollback alone accounts for the bulk of the premium burden shift, making the policy choice unusually clear-cut in its cause and effect.
Gaps in the data and what enrollees should watch next
Several pieces of the picture are still missing. CMS has not yet released 2026 open enrollment public-use files that would show how many people actually selected plans, paid their first premium, or remained enrolled through the year. Until those numbers arrive, analysts must rely on projections and early carrier filings rather than observed take-up rates.
Another blind spot is how consumers will respond to the new price landscape. Some people who lose access to enhanced subsidies may downgrade from silver to bronze plans to keep monthly costs down, accepting higher deductibles and out-of-pocket exposure. Others may leave the marketplace and seek coverage through short-term limited-duration products, employer plans, or Medicaid where eligible. A subset is likely to become uninsured altogether, particularly among those just above the subsidy cliff who do not qualify for other public programs.
Enrollees who stay in the marketplaces will need to pay closer attention to plan design details. The loss of enhanced subsidies does not just raise premiums; it can also change which metal tier offers the best value once cost-sharing reductions and network differences are factored in. For some, a slightly higher premium plan with lower deductibles may still be the better deal over the course of a year, especially if they anticipate significant medical use.
Policy debates heading into 2026 will hinge on whether to restore some version of the enhanced tax credits. Lawmakers weighing that choice face a relatively clean trade-off: additional federal spending versus a measurable reduction in the uninsured rate and improved affordability for middle-income buyers. Because insurer participation remains stable, adjustments to subsidy levels can flow directly to consumers without first having to repair a failing market structure.
For now, the math is straightforward but unforgiving. Without renewed federal action, the typical subsidized marketplace enrollee will keep facing premiums closer to $1,904 than $888, and the projected coverage losses in 2026 could become a reality rather than a warning. The coming enrollment cycle will reveal whether households can absorb that shock-or whether the ACA’s individual market will shrink just as it had begun to stabilize.
